Easy-to-use reporting tool designed to support decision making.
Patient Dynamics is an easy-to-use reporting tool designed to support decision making in pharmaceutical sales and marketing, focusing on patient flows of reimbursed outpatient medications.
Patient Dynamics tool fosters collaboration between key functions in a pharmaceutical company. The tool is specifically designed for the use of business unit heads and, marketing- and sales management, but the whole organization can benefit from understanding and easily accessing key performance data.
Patient Dynamics tool is suitable for reporting business performance and offers easy-to-read answers for common management questions.
The tool can include e.g. reporting of brand performance in the target market and actual patients based on data from the national reimbursement system (KELA).
Medaffcon’s Patient Dynamics Tool Helps to Focus and Find the Right Actions – https://www.medaffcon.fi/en/patient-dynamics-tool-by-medaffcon-helps-to-focus-and-find-the-right-actions/
Multiple myeloma significantly increases the risk of infections. A recent real-world evidence (RWE) study revealed that multiple myeloma (MM) patients experience more infections compared to healthy controls, even prior to diagnosis. Infections, both before and after diagnosis, were associated with an increased mortality.
5th Nordic RWE and AI conference is organized by University of Helsinki and Åbo Akademi University. Register to the event here!
Despite its high-risk nature and availability of kidney treatments, chronic kidney disease (CKD) often goes undiagnosed. This especially concerns patients without type 2 diabetes (T2D), who represent the majority of CKD patients. This finding comes from a recent registry study published in Nephrology Dialysis Transplantation (NDT).
Market Access Specialist & Analyst
MSc (Food Science)
Timo started at Medaffcon in May 2023, bringing his experience and know-how e.g. about developing and utilizing analyses. Timo’s long experience in pharma industry in analytics, marketing and sales gives him a good understanding of the operation of pharmaceutical companies. Timo holds a MSc in Food Economics and Marketing. Market Access and Health economic analyses are new development areas for Timo. In his previous role Timo developed analytical services for pharmaceutical companies.
Timo is inspired about supporting and helping decision making with data. “Data provides a solid foundation for decisions. Data acquired and analyses carried out should be grounded on the decisions made based on them.” Developing new things and overcoming challenges gives Timo energy at work.
Timo believes, that in the future data will be collected and combined from more sources than before. Evaluating effectiveness will be important in decision making in health care and more comprehensive health economic analyses will be needed.